GLOBVAC-Global helse- og vaksin.forskn

SARS-CoV-2 infection and COVID-19 in women and their infants in Kampala, Uganda

Ugandas første bekreftede COVID-19-pasient ble identifisert 22. mars 2020. Fram til utgangen av 2022 hadde i overkant av 170,000 mennesker vært syke med COVID-19. Uganda er estimert å ha hatt 3600 COVID-19 dødsfall (https://coronavirus.jhu.edu/map.html), de fleste blant mennesker med kjente risik...

Awarded: NOK 5.0 mill.

Project Period: 2020-2023

Location: Vestland

SFF-Sentre for fremragende forskn

Centre for Intervention Science in Maternal and Child Health (CISMAC)

Senter for forskning på mødre- og barnehelseintervensjoner (CISMAC) utfører forskning for å bedre mødre-, nyfødt- og barnehelse i lav- og mellominntektsland. Vi evaluerer lovende intervensjoner og bidrar til at forskningsresultater omsettes i praksis. CISMAC er et internasjonalt konsortium med pa...

Awarded: NOK 175.0 mill.

Project Period: 2013-2025

Location: Vestland

GLOBVAC-Global helse- og vaksin.forskn

Joining forces to produce next-generation vaccines against enterotoxigenic Escherichia coli

Infections with enterotoxigenic Escherichia coli (ETEC) remain one of the main contributors to moderate and severe diarrhea (MSD) in children of low- and middle-income countries (LMIC). Extensive efforts to develop vaccines for LMIC children have yet to r esult in an effective ETEC vaccine for us...

Awarded: NOK 0.30 mill.

Project Period: 2013-2014

Location: Vestland

GLOBHELS-Global helse

Developing vaccines against diarrhea caused by Enterotoxigenic Escherichia coli and Shigella (EntVac)

Diarrhea and dysentery are important killers of children in developing countries. These diseases also contribute to malnutrition. Vaccines give a very favorable return on public health investment, and a polyvalent anti-diarrheal vaccine would greatly impr ove this investment case. But efforts to ...

Awarded: NOK 15.2 mill.

Project Period: 2008-2014

Location: Vestland

GLOBHELS-Global helse

Evaluation of the Impact of the Integrated Management of Neonatal and Childhood Illness Strategy on Neonatal and Infant Mortality

This is a recently initied cluster-randomized trial in Haryana, North India. Eighteen geographical areas served by Primary Health Centres (PHCs) (average population 30,000) were randomized to intervention or comparison areas. The IMNCI intervention includ es three main components: a) improvements...

Awarded: NOK 7.4 mill.

Project Period: 2008-2012

Location: Oslo

GLOBHELS-Global helse

Project establishment: Development of vaccine(s) against infections with diarrheagenic Escherichia coli and Shigella

Diarrheal diseases are the second most common cause of death in children, accounting for 1/5 of the 10.6 million annual child deaths. In addition, repeated episodes of diarrhea, especially if prolonged and associated with growth faltering, are an importan t cause of malnutrition in developing cou...

Awarded: NOK 0.30 mill.

Project Period: 2007-2007

Location: Vestland

AS-HEL-Samfunnsmedisin og helsetj.

Childhood diarrheal disease and nutrition prosject

...

Awarded: NOK 0.23 mill.

Project Period: 2004-2005

Location: Vestland

GAVI-Norsk GAVI-nettverk

GAVI-oriented research at the Centre for International Health: Participation in a rotavirus vaccine trial.

...

Awarded: NOK 0.80 mill.

Project Period: 2001-2005

Location: Vestland